SNCA and Alzheimer disease: On the other hand, the first evidence of α-syn in the human central nervous system (CNS) occurred in 1993, with the isolation of a protein included in the amyloid plaques of patients affected by Alzheimer’s disease (AD), and was therefore defined as NACP (non-amyloid-β component protein) [4].